India Proposes Immediate Licence Suspensions for Drug Quality Failures
Proposed rules would require regulators to immediately suspend medicine manufacturing licences when government testing finds products fail specified quality standards.
Related stories
White House Schedules December 14 Hearing on Fed Governor Cook
The New York Times, citing an unnamed White House official, reported that the hearing concerns allegations of mortgage fraud and is part of President Donald Trump's effort to fire
M impact | REGULATION | Nov 04, 2026, 11:44 PM UTC
Cayson Acquisition Faces Nasdaq Delisting Over Shareholder Rule
Cayson Acquisition faces delisting from Nasdaq for failing to meet a minimum shareholder requirement.
M impact | REGULATION | Nov 04, 2026, 11:24 PM UTC
FDA grants tentative approval to low-cost HIV shot
The potential rollout of a more affordable injection to help prevent HIV infection lifts hopes for reduced AIDS deaths in Africa. US regulators’ approval of a cheaper HIV shot has
L impact | REGULATION | Nov 04, 2026, 10:45 PM UTC
Nasdaq Initiates Delisting Procedures for Cayson Acquisition
Nasdaq said Cayson Acquisition had not met the 400-holder requirement for its ordinary shares. The company appealed by the November 5 deadline.
M impact | REGULATION | Nov 04, 2026, 10:31 PM UTC
NYSE American Suspends Green Circle Trading Over Low Share Price
NYSE American suspended trading in Green Circle's shares on Nov. 3, 2026, after finding them unsuitable for listing because of their low selling price. The company intends to reque
M impact | REGULATION | Nov 04, 2026, 08:56 PM UTC
US Judge Bars DOJ From Tying State Grants to Immigration Enforcement
M impact | REGULATION | Nov 04, 2026, 08:46 PM UTC